Skip to main content
. Author manuscript; available in PMC: 2015 May 2.
Published in final edited form as: J Nucl Med. 2014 Apr 28;55(7):1062–1068. doi: 10.2967/jnumed.113.136770

FIGURE 4.

FIGURE 4

Added value of PET/CT to clinical assessment. PET/CT was helpful in excluding tumor in 15.2% (37/243) of patients with clinical suspicion of recurrence and in identifying recurrence in 43.7% (107/245) of patients with no prior clinical suspicion.